Literature DB >> 28993266

A "protective umbrella" nanoplatform for loading ICG and multi-modal imaging-guided phototherapy.

Jie Zhou1, Lingchang Meng2, Chong Sun2, Weiran Ye2, Chengqun Chen3, Bin Du4.   

Abstract

In order to prevent the aggregation of ICG and enhance its stability, a novel nanoplatform (TiO2:Yb,Ho,F-β-CD@ICG/HA) was designed for NIR-induced phototherapy along with multi-mode imaging(UCL/MRI/Flu). In this nanosysytem: TiO2:Yb,Ho,F was used as upconversion materials and applied in vivo for the first time; β-CD acted as a "protective umbrella" to load separated ICG and avoid the low phototherapy efficiency because of its aggregation; HA was the capping agent of β-CD to prevent ICG unexpected leaking and a target to recognize CD44 receptor. The nanosystem exhibited excellent size (~200 nm) and photo- and thermal-stability, preferable reactive oxygen yield and temperature response (50.4 °C) under 808 nm laser. It could efficiently target and suppress tumor growth. The imaging ability (UCL/MRI) of TiO2:Yb,Ho,F could facilitate diagnosis of the tumor, especially for deep tissues. Altogether, our work successfully improved the phototherapy efficacy through incorporating the ICG into the cavity of β-CD and applied TiO2:Yb,Ho,F for upconversion imaging in vivo.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Improving the stability; Indocyanine green; NIR-induced; Photodynamic therapy; Photothermal therapy

Mesh:

Substances:

Year:  2017        PMID: 28993266     DOI: 10.1016/j.nano.2017.09.009

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  3 in total

1.  Indocyanine Green and Methyl-β-Cyclodextrin Complex for Enhanced Photothermal Cancer Therapy.

Authors:  Gayoung Jo; Bo Young Lee; Eun Jeong Kim; Min Ho Park; Hoon Hyun
Journal:  Biomedicines       Date:  2020-11-05

Review 2.  MRI-traceable theranostic nanoparticles for targeted cancer treatment.

Authors:  Tareq Anani; Shiva Rahmati; Nayer Sultana; Allan E David
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

3.  Novel albumin-binding photothermal agent ICG-IBA-RGD for targeted fluorescent imaging and photothermal therapy of cancer.

Authors:  Cheng Yu; Enhua Xiao; Pengfei Xu; Jingjing Lin; Linan Hu; Jie Zhang; Shengzhen Dai; Zhuyuan Ding; Yuyang Xiao; Zhu Chen
Journal:  RSC Adv       Date:  2021-02-11       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.